TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ALKS

Alkermes Plc

Healthcare · Drug Manufacturers - Specialty & Generic

43.30$ -2.0% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Alkermes Plc (ALKS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 4,393 million $. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ALKS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
2,279 2,136 2,124 2,207 2,155 2,056 2,082 2,253 2,330 2,530 4,258 4,393
1,465 1,486 1,469 1,542 1,564 1,415 1,479 1,635 1,742 1,929 1,359 1,523
648 457 421 535 396 291 400 521 616 1,120 352 512
889 773 745 876 909 752 884 1,016 1,111 1,319 512 657
340 333 317 370 370 390 322 355 355 334 408 456
192 186 198 195 191 183 183 192 191 197 337 299
431
93 83 83 83 83 83 84 596 594
11 2.0 0.9 0.9 0.9 0.9 84 84 84 84 1,784 1,761
924 934 869 923 863 591 570 628 596 711 2,507 2,585
503 520 459 516 454 465 444 506 474 543 599 662
18 8.7 8.9 9.0 9.2 6.2 6.3 6.5 6.6 6.7 34 34
87 66 77 105 37 46 60 99 68 108 102 143
288 288 287 286 286 1,484
1,356 1,203 1,255 1,284 1,292 1,465 1,512 1,625 1,733 1,819 1,752 1,809
-1,456 -1,344 -1,307 -1,215 -1,123 -976 -954 -867 -784 -735 -801 -801
172 170 173 171 167 167 169 168 169 169 166 167

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?